Menu
Washington DC
DC Dispensaries
DC Weed Reviews
DC Medical Reviews
DC Delivery Services
How to Buy Weed in DC
I-71 Information
History of Legal Weed in DC
DC Medical Marijuana Guide
Virginia
Find the BEST weed in...
Business of Cannabis Returns to New York for 2025 Summit
Sep 29, 2025
Mg Magazine Newswire
MG Magazine
*NEW YORK* — The Business of Cannabis: New York Summit returns Wednesday,
November 6. Now in its fifth year, the summit will take place at the
boutique Wythe Hotel in Williamsburg. With 75% of access strictly by
invitation, the day-long event is designed for senior executives,
investors, regulators, and policymakers who are actively defining the
trajectory of the industry.
This year’s Summit debuts a new format. Gone are the agendas and panels.
Rather, guests will experience curated 1-on-1 executive exchanges,
confidential roundtables, and strategic, curated networking sessions
designed to accelerate partnerships, funding, and policy alignment.
This year’s lineup will once again spotlight those moving the needle, from
retailers and regulators to investors and innovators, including:
- Fab 5 Freddy (Fred Brathwaite), a central figure in the emergence of
hip-hop from an art form born in The Bronx to a global phenomenon.
- L. Simone Washington, Chief Equity Officer of the New York Office of
Cannabis Management.
- Joanne Wilson, CEO of Gotham.
- Seth Yakatan, Co-founder of Katan Associates.
- David E. Vautrin, CEO of FLUENT.
- Amy Deneson, Executive Director and Co-Founder of the Cannabis Media
Council.
New York is at a critical moment. With over $2 billion in legal cannabis
sales since the adult-use market launched nearly three years ago, the state
is fast becoming a global focal point, offering a rare combination of
regulatory evolution, cultural capital, and capital investment
opportunities. Yet, major challenges persist such as inconsistent
regulation, inversion, a delayed track-and-trace system, and licensing
bottlenecks.
The Summit agenda will tackle these head-on, with focused discussions on:
- Regulatory uncertainty and public perception.
- Market saturation and retail evolution.
- Growth of the medical market.
- Funding trends and investment strategy.
This year’s experience is built around impact-first design:
- Executive Exchanges: No big panels, just candid, on-stage dialogues
between regulators, CEOs, and investors to really get under the skin of
issues & opportunities.
- Strategic Matchmaking and Roundtables: Tables curated through
confidential attendee insights.













